Reports have demonstrated CNTN1 to be upregulated in many types of cancer such as lung cancer, oesophageal squamous cell carcinomas, gastric cancer, thyroid cancer, prostate cancer and hepatocellular carcinoma, suggesting its contribution to carcinoma progression, invasion, and metastasis (Li et al., 2021). This evidence concerns the gene CNTN1 and thyroid cancer.